Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …

Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD)
in the United States. Risk factor modification, such as tight control of blood glucose, …

In the United States, hemodialysis remains the most common treatment modality for kidney
failure, chosen by almost 90% of incident patients. A functioning vascular access is key to …

… Author links open overlay panel Jonathan J. Taliercio DO 1 , Jesse D. Schold PhD 1 2 , James
F. Simon MD 1 , Susana Arrigain MA 2 , Anne Tang MS 2 , Georges Saab MD 3 , Joseph V…

Introduction Magnesium disorders are commonly encountered in chronic kidney disease (CKD)
and are typically a consequence of decreased kidney function or frequently prescribed …

Introduction: Metabolomics could offer novel prognostic biomarkers and elucidate
mechanisms of diabetic kidney disease (DKD) progression. Via metabolomic analysis of urine …

Rationale & Objectives Adiposity and physical fitness levels are major drivers of cardiometabolic
risk, but these relationships have not been well-characterized in chronic kidney disease …

Background Prior studies of adverse renal consequences of AKI have almost exclusively
focused on eGFR changes. Less is known about potential effects of AKI on proteinuria, …

Rationale & Objective The utility of conventional upper reference limits (URL) for N-terminal
pro–brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hsTnT) in …

Results In our study, 24% of participants reported nonsteroidal anti-inflammatory drug use at
baseline or at least one follow-up study visit. Having a 10 ml/min per 1.73 m 2 higher eGFR …